Kevin T. Conroy
President and Chief Executive Officer
Kevin T. Conroy was named President and Chief Executive Officer of Exact Sciences in April 2009. He also serves as a Director. In December 2005, he was appointed President and Chief Executive of Third Wave, and served in that position until the company's acquisition by Hologic in July 2008. He joined Third Wave in July 2004 and served as the company's general counsel until December 2005. Prior to joining Third Wave, Conroy served as Intellectual Property counsel at GE Healthcare. Before joining GE Healthcare, Conroy was Chief Operating Officer of two early stage, venture-backed technology companies in Northern California. Prior to those positions, he was an Intellectual Property litigator at two Chicago law firms: McDermott Will & Emery; and Pattishall, McAuliffe, Newbury, Hilliard and Geraldson, where he was a partner. He earned a Bachelor of Science degree in electrical engineering from Michigan State University, as well as a law degree from the University of Michigan Law School.

Graham P. Lidgard
Chief Science Officer
Graham P. Lidgard, Ph.D., was appointed Chief Science Officer of Exact Sciences in August 2009. Dr. Lidgard led the research and development organization at Gen-Probe Inc. that developed that company's Procleix blood screening products and Aptima sexually transmitted disease products. Dr. Lidgard also created and led the system development group at Gen-Probe that developed its fully automated Tigris system. Prior to joining Gen-Probe, Dr. Lidgard was co-founder and Vice President of product development of Matritech Inc., a Cambridge, Massachusetts-based developer of diagnostic products for the early detection of bladder cancer. Before he co-founded Matritech, Dr. Lidgard held senior positions at Ciba Corning Diagnostics Corp.’s worldwide diagnostics group. While at Ciba Corning, he was involved in the development of more than 70 510(k)-cleared products. He led the program for the development of the magnetic particle chemiluminescent technology that became the ACS:180 and Centaur systems. Dr. Lidgard joins Exact Sciences from Nanogen Inc., where he was Senior Vice President of research and development. Dr. Lidgard earned a Bachelor's degree with honors and a Doctorate in biological chemistry from the University of Manchester in England.

Maneesh K. Arora
Senior Vice President and Chief Financial Officer
Maneesh K. Arora was appointed Senior Vice President and Chief Financial Officer of Exact Sciences in April 2009. Prior to joining Exact Sciences, Maneesh served as Chief Financial Officer of Third Wave Technologies, a molecular diagnostic company focused on cervical cancer screening, from January 2006 until the company's acquisition by Hologic in July 2008. He joined Third Wave in January 2003 as Director of Strategy and was promoted successively to Vice President and Senior Vice President in 2004. Prior to joining Third Wave, Arora was Director of Corporate Strategy for Nalco Chemical Company. He began his career at Kraft Foods as a financial analyst and held several positions of increasing responsibility during his nine years there. Arora earned a Bachelor's degree in economics from the University of Chicago and a Master of Business Administration from the Kellogg Graduate School of Management.

Barry M. Berger, MD
Chief Medical Officer
Barry M. Berger, MD, joined Exact Sciences in 1999. He received his medical degree from the University of Pennsylvania. Berger held a faculty appointment at Harvard Medical School and has been affiliated staff in Pathology at Brigham and Women's Hospital since 1982. His post-graduate training includes a post-doctoral fellowship in immunology (University of Pennsylvania), medical internship at Boston University Hospital, and Residency/Chief Resident in Pathology at Brigham and Women's Hospital in Boston, MA. Berger is boarded in Anatomic, Clinical and Cytologic pathology. Earlier in his career, Berger spent 11 years as the Director of the Department of Pathology and Laboratory Medicine of Harvard Pilgrim Healthcare. He is the past chairman of the Advisory Committee on Clinical Laboratories for the Commonwealth of MA and currently serves on the Executive Committee of the Massachusetts Society of Pathologists, the Economics Committee of the American College of Medical Genetics, and the Health policy Task Group of the National Colorectal Cancer Roundtable.